Antiseizure medication discontinuation: A mixed-methods exploration of factors considered by patients when approaching decision-making
Numerous themes emerged including reasons favoring continued ASMs (e.g., fear of seizures and their psychosocial consequences, perceiving little downside to continued ASMs) but also many reasons against continued ASMs (e.g., side effects, inconvenience). Discussions surrounding how long to continue ASMs should be highly individualized given the heterogeneity of patient preferences regarding treatment and counseling.
Authors
- Samuel W. Terman (ORCID: https://orcid.org/0000-0001-6179-9467)
- Margaret Dugan
- Chloé E. Hill (ORCID: https://orcid.org/0000-0001-5307-4167)
- James Francis Burke (ORCID: https://orcid.org/0000-0002-2296-1588)
- Neena Kalia (ORCID: https://orcid.org/0000-0003-2960-7829)
- Arthur C. Grant (ORCID: https://orcid.org/0000-0002-0509-8065)
- Susanna S. O’Kula
- Jasper Lee (ORCID: https://orcid.org/0000-0003-0472-827X)
- Palak Patel (ORCID: https://orcid.org/0000-0001-5805-3023)
- Katherine Mortati
- Amanda Brand (ORCID: https://orcid.org/0000-0002-2421-1414)
- Kara Manuel
- Jordan M Silva
- M M Reid
- Max Kuster
- Alexandra Tolmasov
Institutions
- State University of New York (US)
- SUNY Downstate Health Sciences University (US)
- University of Michigan (US)
- Michigan Medicine (US)
- Hackensack Meridian Health (US)
- Center for Discovery (US)
- The Ohio State University (US)
Publication Details
- Journal
- Epilepsy Research
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1016/j.eplepsyres.2025.107615
- Citations
- 2
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.94